First-in-human safety and pharmacokinetics of MK-7602, the antimalarial inhibitor of plasmepsins IX/X, in single- and multiple-ascending-dose studies. (journals.asm.org)

Authors: Stanley SE … Nussbaum J Journal: Antimicrobial Agents and Chemotherapy Published: 2026-02-04 DOI: https://doi.org/10.1128/aac.01261-25